Wolverine Trading’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-18,390
| Closed | -$168K | – | 6101 |
|
|
2025
Q2 | $168K | Buy |
18,390
+6,755
| +58% | +$49.7K | ﹤0.01% | 3992 |
|
|
2025
Q1 | $96.3K | Buy |
+11,635
| New | +$85.2K | ﹤0.01% | 4242 |
|
|
2022
Q1 | – | Sell |
-10,763
| Closed | -$405K | – | 6313 |
|
|
2021
Q4 | $465K | Sell |
10,763
-4,530
| -30% | -$190K | ﹤0.01% | 3558 |
|
|
2021
Q3 | $675K | Buy |
15,293
+2,312
| +18% | +$106K | ﹤0.01% | 3522 |
|
|
2021
Q2 | $732K | Sell |
12,981
-2,769
| -18% | -$196K | ﹤0.01% | 3179 |
|
|
2021
Q1 | $1.15M | Buy |
15,750
+9,199
| +140% | +$754K | ﹤0.01% | 2563 |
|
|
2020
Q4 | $581K | Buy |
6,551
+1,009
| +18% | +$74.4K | ﹤0.01% | 2990 |
|
|
2020
Q3 | $331K | Sell |
5,542
-580
| -9% | -$29.4K | ﹤0.01% | 3272 |
|
|
2020
Q2 | $256K | Buy |
+6,122
| New | +$222K | ﹤0.01% | 3522 |
|
|
2019
Q1 | – | Sell |
-5,111
| Closed | -$455K | – | 5200 |
|
|
2018
Q4 | $455K | Sell |
5,111
-3,049
| -37% | -$349K | ﹤0.01% | 2725 |
|
|
2018
Q3 | $1.15M | Buy |
+8,160
| New | +$1.26M | ﹤0.01% | 2191 |
|
|
2018
Q1 | – | Sell |
-9,798
| Closed | -$1.61M | – | 5737 |
|
|
2017
Q4 | $1.61M | Buy |
9,798
+814
| +9% | +$78.9K | 0.01% | 1721 |
|
|
2017
Q3 | $560K | Buy |
8,984
+4,004
| +80% | +$314K | ﹤0.01% | 2491 |
|
|
2017
Q2 | $393K | Buy |
+4,980
| New | +$360K | ﹤0.01% | 2688 |
|
|
2017
Q1 | – | Sell |
-9,680
| Closed | -$494K | – | 4899 |
|
|
2016
Q4 | $494K | Buy |
9,680
+1,460
| +18% | +$68.8K | ﹤0.01% | 2640 |
|
|
2016
Q3 | $374K | Buy |
+8,220
| New | +$335K | ﹤0.01% | 2939 |
|
Other funds holding SAGE
IA
HNB